Carpal Tunnel Syndrome Market Size to Worth USD 1,328.69 Mn by 2032
24 mai 2024 10h05 HE
|
Precedence Research
Ottawa, May 24, 2024 (GLOBE NEWSWIRE) -- The global carpal tunnel syndrome market size was valued at USD 942.69 million in 2023 and is predicted to hit around USD 1,232.21 million by 2031, a study...
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device
16 févr. 2021 09h30 HE
|
PAVmed Inc.
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
SWORD Health to Relieve Pandemic-Induced Carpal Tunnel Syndrome by Adding Wrist Therapy to its Virtual Musculoskeletal Care Solution
27 oct. 2020 12h08 HE
|
SWORD Health
NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Complaints of Carpal Tunnel Syndrome and other wrist conditions are on the rise since people bolted from their ergonomically-designed workspaces earlier...
PAVmed Subsidiary Lucid Diagnostics Partners with Fred Hutchinson Cancer Research Center to Evaluate Barrett’s Esophagus (BE) Progression Biomarkers Using EsoCheck™
20 févr. 2020 09h30 HE
|
PAVmed Inc.
Lucid secures exclusive option to license biomarker technology to detect progression from nondysplastic to dysplastic BE using EsoCheck to allow curative ablation before deadly esophageal cancer...
U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test
11 févr. 2020 09h30 HE
|
PAVmed Inc.
NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
USPTO Grants PAVmed Patent Covering its CarpX™ Device
21 août 2019 09h30 HE
|
PAVmed Inc.
NEW YORK, Aug. 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the U.S....
PAVmed Provides Business Update
26 févr. 2019 07h30 HE
|
PAVmed Inc.
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update
15 nov. 2018 07h30 HE
|
PAVmed Inc.
Conference call to be held on November 15, 2018 at 4:30 p.m. Eastern time NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVmed to Hold Business Update Conference Call on November 15, 2018
01 nov. 2018 07h30 HE
|
PAVmed Inc.
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVmed to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
23 oct. 2018 07h30 HE
|
PAVmed Inc.
NEW YORK, Oct, Oct. 23, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that...